Who owns MATINAS BIOPHARMA HLDGS INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Matinas Biopharma Hldgs with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Matinas Biopharma Hldgs stock

Who bought or sold MATINAS BIOPHARMA HLDGS INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Vanguard Group 107k $54k -43% Dec 2024
 View chart
Sargent Investment Group 64k $38k -20% Dec 2024
 View chart
BlackRock 50k $25k 0% Dec 2024
 View chart
Geode Capital Management 44k $22k -7% Dec 2024
 View chart
Susquehanna International 24k $12k 100% Dec 2024
 View chart
Renaissance Technologies 18k $9.3k 100% Dec 2024
 View chart
State Street Corporation 15k $7.8k 0% Dec 2024
 View chart
UBS Group 12k $6.3k 259% Dec 2024
 View chart
Tower Research Capital 1.1k $562.020000 100% Dec 2024
 View chart
Bank of America Corporation 975.00 $496.957500 -4% Dec 2024
 View chart
Jpmorgan Chase & Co 904.00 $461.040000 -1% Dec 2024
 View chart
Advisor Group Holdings 200.00 $707.000000 0% Dec 2024
 View chart
Morgan Stanley 144.00 $72.993600 -72% Dec 2024
 View chart
Wells Fargo & Company 102.00 $51.999600 -91% Dec 2024
 View chart
Steward Partners Investment Advisory 61.00 $31.000200 0% Dec 2024
 View chart
EverSource Wealth Advisors 60.00 $31.002000 0% Dec 2024
 View chart
Royal Bank of Canada 35.00 $0 100% Dec 2024
 View chart
Rothschild Investment 14.00 $49.999600 100% Sep 2024
 View chart
SBI Securities 11.00 $6.000500 100% Dec 2024
 View chart
IFP Advisors 2.00 $1.000000 100% Dec 2024
 View chart
Goss Wealth Management 1.00 $1.000000 100% Dec 2024
 View chart

Who sold out of Matinas Biopharma Hldgs?

Fund or Company Name Date Sold Shares Held Valued At
Highbridge Capital Management Sep 2024 129k $457k
Squarepoint Ops Sep 2024 21k $73k
Sanctuary Advisors Sep 2024 10k $6.2k